Jeffrey Eisele - Chief Development Officer at Apellis Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Development Officer
Issuer Symbol
APLS on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Jeffrey Eisele since 11 Mar 2025

Holdings reported by Jeffrey Eisele for Apellis Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 55,312 $1,633,009 $29.52 29 Jan 2025 Direct

Transactions reported by Jeffrey Eisele for Apellis Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.